| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |